The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2026

Filed:

Feb. 02, 2023
Applicant:

Clearnote Health, Inc., San Mateo, CA (US);

Inventors:

Samuel Levy, San Mateo, CA (US);

Patrick A. Arensdorf, Palo Alto, CA (US);

Chin-Jen Ku, San Mateo, CA (US);

Francois Collin, San Mateo, CA (US);

Assignee:

ClearNote Health, Inc., San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G06F 17/18 (2006.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G06F 17/18 (2013.01); G16H 50/30 (2018.01); C12Q 2537/164 (2013.01); C12Q 2600/154 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/60 (2013.01); G01N 2800/7028 (2013.01);
Abstract

Disclosed herein are methods for identifying patients with pancreatic cancer and subjects at risk for developing pancreatic cancer, methods for monitoring a patient with an identified pancreatic lesion, methods for evaluating the effectiveness of a treatment used for a patient with pancreatic cancer, and methods for selecting a therapy for treating pancreatic cancer in a particular patient. The invention makes use of hydroxymethylation biomarkers, which in combination with one or more clinical parameters and optionally one or more additional types of biomarkers and/or patient-specific risk factors, exhibit a hydroxymethylation level that correlates with pancreatic cancer. Kits and other methods of use are also provided.


Find Patent Forward Citations

Levy, Samuel. (2026). Cell-free dna hydroxymethylation profiles in the evaluation of pancreatic lesions (U.S. Patent No. 12760374). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12760374

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…